Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Nadia Milad, Mathieu C. Morissette. Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021

Member's Comments

No comment yet.

Related content which might interest you: Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020 The role of surfactant on chronic infant lung disease Source: Annual Congress 2003 - Chronic infant lung disease Year: 2003 The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 The role of inflammation in prevalence of chronic obstructive pulmonary diseases in wood workers Source: Eur Respir J 2007; 30: Suppl. 51, 599s Year: 2007 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases Source: Eur Respir Monogr 2017; 77: 224-246 Year: 2017 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Interplay between bacterial infections, hypoxia and the development of chronic lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 How systemic inflammatory diseases affect the lung Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 The impact of airborne occupational exposure in chronic obstructive pulmonary disease Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD Year: 2010 COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The role of prooxidant effect of metals with variable valiancy in pathogenesis of chronic obstructive diseases of lungs Source: Eur Respir J 2002; 20: Suppl. 38, 96s Year: 2002 Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Effect of 3-week pulmonary rehabilitation on airway inflammation in patients with chronic obstructive lung diseases Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Early-life pulmonary immunity and development of paediatric inflammatory respiratory diseases Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach Year: 2019 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021